Label: CYCLOBENZAPRINE HYDROCHLORIDE tablet, film coated

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated February 19, 2021

If you are a consumer or patient please visit this version.

  • INDICATIONS & USAGE

    Cyclobenzaprine hydrochloride tablets are indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions.

    Improvement is manifested by relief of muscle spasm and its associated signs and symptoms, namely, pain, tenderness, limitation of motion, and restriction in activities of daily living.

    Cyclobenzaprine hydrochloride tablets should be used only for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use is not available and because muscle spasm associated with acute, painful musculoskeletal conditions is generally of short duration and specific therapy for longer periods is seldom warranted.

    Cyclobenzaprine hydrochloride tablets have not been found effective in the treatment of spasticity associated with cerebral or spinal cord disease, or in children with cerebral palsy.

  • PRINCIPAL DISPLAY PANEL

    Cyclobenzaprine Hydro Bottle

  • INGREDIENTS AND APPEARANCE
    CYCLOBENZAPRINE HYDROCHLORIDE 
    cyclobenzaprine hydrochloride tablet, film coated
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:80175-0400(NDC:43547-400)
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CYCLOBENZAPRINE HYDROCHLORIDE (UNII: 0VE05JYS2P) (CYCLOBENZAPRINE - UNII:69O5WQQ5TI) CYCLOBENZAPRINE HYDROCHLORIDE10 mg
    Product Characteristics
    ColoryellowScoreno score
    ShapeROUNDSize7mm
    FlavorImprint Code 2632;V
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:80175-0400-330 in 1 BOTTLE; Type 0: Not a Combination Product03/30/2017
    2NDC:80175-0400-660 in 1 BOTTLE; Type 0: Not a Combination Product03/30/2017
    3NDC:80175-0400-990 in 1 BOTTLE; Type 0: Not a Combination Product03/30/2017
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA07779703/30/2017
    Labeler - Central Packaging (117617671)
    Establishment
    NameAddressID/FEIBusiness Operations
    Central Packaging, LLC117617671repack(80175-0400)